Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$120.85 -0.4  -0.3%

Last Trade - 7:55pm

Sector
Healthcare
Size
Large Cap
Market Cap £12.46bn
Enterprise Value £15.30bn
Revenue £5.76bn
Position in Universe 537th / 6400

UPDATE 1-Quest Diagnostics launches coronavirus testing for employees returning to work

Wed 27th May, 2020 2:49pm
(Adds details on the services)
    May 27 (Reuters) - Quest Diagnostics Inc  DGX.N  on
Wednesday launched services to support large-scale testing for
the new coronavirus as companies look to bring employees back to
offices safely.
   The company in April started testing blood samples to detect
antibodies - proteins produced in response to infection -
against COVID-19, the respiratory disease caused by the
coronavirus.  urn:newsml:reuters.com:*:nL3N2C91YB
   The diagnostic company said the "return to work services"
provide employers access to its COVID-19 antibody testing as
well as molecular testing, which typically uses nasal swab
samples to detect the virus. 
   The company said it was scaling up its COVID-19 lab
operations to accommodate expected demand and expects to have
capacity for about 150,000 molecular diagnostic tests a day by
the end of June, nearly double its current testing
rate. urn:newsml:reuters.com:*:nPn455sy3a
    The company also said it has the capacity to perform about
200,000 antibody tests a day.

 (Reporting by Manojna Maddipatla in Bengaluru; Editing by
Shinjini Ganguli)
 ((manojna.kalyani@thomsonreuters.com; +91  8061822700;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.